Mapping the stem cell state: Eight novel human embryonic stem and embryonal carcinoma cell antibodies

International Journal of Andrology

Volumn 34, Issue 4 PART 2, 2011, Pages

  Wright, A ^a   Andrews, N ^a   Bardsley, K ^a   Nielsen, J E ^b   Avery, K ^a   Pewsey, E ^a   Jones, M ^a   Harley, D ^a   Nielsen, A R ^b   Moore, H ^a   Gokhale, P ^a   Rajpert De Meyts, E ^b   Andrews, P W ^a   Walsh, J ^a   Harrison, N J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b University of Copenhagen   (Denmark)

Author keywords

Antibodies; Cancer; Cell differentiation; Embryonic stem cells; Testicular neoplasms

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; BIOCHEMISTRY; CELL COMPARTMENTALIZATION; CELL LINE; CELL MATURATION; CONTROLLED STUDY; CROSS REACTION; EMBRYO; EMBRYONAL CARCINOMA; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; FEMALE; GERM CELL TUMOR; HUMAN; HUMAN CELL; MALE; MOLECULAR RECOGNITION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL LINE; EMBRYONAL CARCINOMA STEM CELLS; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 79960881356     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2011.01185.x     Document Type: Article

References (46)

1. Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G et al. (2007) Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25, 803-816.
2. Aflatoonian B, Ruban L, Shamsuddin S, Baker D, Andrews P & Moore H. (2010) Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system. In Vitro Cell Dev Biol Anim 46, 236-241.
3. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J & Thomson JA. (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227, 271-278.
4. Andrews PW. (1984) Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 103, 285-293.
5. Andrews PW, Bronson DL, Benham F, Strickland S & Knowles BB. (1980) A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer 26, 269-280.
6. Andrews PW, Knowles BB & Goodfellow PN. (1981) A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on chromosome 12. Somatic Cell Genet 7, 435-443.
7. Andrews PW, Goodfellow PN, Shevinsky LH, Bronson DL & Knowles BB. (1982) Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int J Cancer 29, 523-531.
8. Andrews PW, Banting G, Damjanov I, Arnaud D & Avner P. (1984a) Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3, 347-361.
9. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC & Fogh J. (1984b) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50, 147-162.
10. Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J et al. (1996) Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer 66, 806-816.
11. Badcock G, Pigott C, Goepel J & Andrews PW. (1999) The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res 59, 4715-4719.
12. Boyse EA & Old LJ. (1969) Some aspects of normal and abnormal cell surface genetics. Annu Rev Genet 3, 269-290.
13. Bronson DL, Andrews PW, Solter D, Cervenka J, Lange PH & Fraley EE. (1980) Cell line derived from a metastasis of a human testicular germ cell tumor. Cancer Res 40, 2500-2506.
14. Bronson DL, Vessella RL & Fraley EE. (1984) Differentiation potential of human embryonal carcinoma cell lines. Cell Differ 15, 129-132.
15. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C & Rubinstein E. (2001) The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276, 14329-14337.
16. Dick JE. (2008) Stem cell concepts renew cancer research. Blood 112, 4793-4807.
17. Enver T, Soneji S, Joshi C, Brown J, Iborra F, Orntoft T et al. (2005) Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 14, 3129-3140.
18. Enver T, Pera M, Peterson C & Andrews PW. (2009) Stem cell states, fates, and the rules of attraction. Cell Stem Cell 4, 387-397.
19. Fenderson BA, Andrews PW, Nudelman E, Clausen H & Hakomori S. (1987) Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol 122, 21-34.
20. Fenderson BA, Radin N & Andrews PW. (1993) Differentiation antigens of human germ cell tumours: distribution of carbohydrate epitopes on glycolipids and glycoproteins analyzed using PDMP, an inhibitor of glycolipid synthesis. Eur Urol 23, 30-36. discussion 36-37.
21. Fogh J & Trempe G. (1975) New Tumor Cell Lines. Plenum Press, New York.
22. Horvath A, Sutterlin C, Manning-Krieg U, Movva NR & Riezman H. (1994) Ceramide synthesis enhances transport of GPI-anchored proteins to the Golgi apparatus in yeast. EMBO J 13, 3687-3695.
23. Inokuchi J, Momosaki K, Shimeno H, Nagamatsu A & Radin NS. (1989) Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells. J Cell Physiol 141, 573-583.
24. Kannagi R, Cochran NA, Ishigami F, Hakomori S, Andrews PW, Knowles BB & Solter D. (1983) Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2, 2355-2361.
25. King FW, Ritner C, Liszewski W, Kwan HC, Pedersen A, Leavitt AD & Bernstein HS. (2009) Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. Stem Cells Dev 18, 1441-1450.
26. Kleinsmith LJ & Pierce GB Jr. (1964) Multipotentiality of single embryonal carcinoma cells. Cancer Res 24, 1544-1551.
27. Knowles BB, Howe CC & Aden DP. (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209, 497-499.
28. Kohler G & Milstein C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
29. Laslett AL, Grimmond S, Gardiner B, Stamp L, Lin A, Hawes SM, Wormald S, Nikolic-Paterson D, Haylock D & Pera MF. (2007) Transcriptional analysis of early lineage commitment in human embryonic stem cells. BMC Dev Biol 7, 12.
30. Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC & Mabry ND. (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36, 4562-4569.
31. Lin SA, Kolle G, Grimmond SM, Zhou Q, Doust E, Little MH et al. (2010) Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors. Stem Cells Dev 19, 1637-1648.
32. McBurney MW, Jones-Villeneuve EM, Edwards MK & Anderson PJ. (1982) Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299, 165-167.
33. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, Chien KR & Melton DA. (2008) Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26, 313-315.
34. Pattillo RA, Gey GO, Delfs E, Huang WY, Hause L, Garancis DJ et al. (1971) The hormone-synthesizing trophoblastic cell in vitro: a model for cancer research and placental hormone synthesis. Ann N Y Acad Sci 172, 288-298.
35. Pera MF, Filipczyk AA, Hawes SM & Laslett AL. (2003) Isolation, characterization, and differentiation of human embryonic stem cells. Methods Enzymol 365, 429-446.
36. Scherer WF, Syverton JT & Gey GO. (1953) Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med 97, 695-710.
37. Shevinsky LH, Knowles BB, Damjanov I & Solter D. (1982) Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30, 697-705.
38. Shulman M, Wilde CD & Kohler G. (1978) A better cell line for making hybridomas secreting specific antibodies. Nature 276, 269-270.
39. Sincock PM, Mayrhofer G & Ashman LK. (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 45, 515-525.
40. Solter D & Knowles BB. (1978) Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75, 5565-5569.
41. Sonne SB, Perrett RM, Nielsen JE, Baxter MA, Kristensen DM, Leffers H, Hanley NA & Rajpert-De-Meyts E. (2010) Analysis of SOX2 expression in developing human testis and germ cell neoplasia. Int J Dev Biol 54, 755-760.
42. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS & Jones JM. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
43. Tonge PD, Olariu V, Coca D, Kadirkamanathan V, Burrell KE, Billings SA & Andrews PW. (2010) Prepatterning in the stem cell compartment. PLoS ONE 5, e10901.
44. Vogelzang NJ, Bronson D, Savino D, Vessella RL & Fraley EF. (1985) A human embryonal-yolk sac carcinoma model system in athymic mice. Cancer 55, 2584-2593.
45. Williams BP, Daniels GL, Pym B, Sheer D, Povey S, Okubo Y, Andrews PW & Goodfellow PN. (1988) Biochemical and genetic analysis of the OKa blood group antigen. Immunogenetics 27, 322-329.
46. Wright AJ & Andrews PW. (2009) Surface marker antigens in the characterization of human embryonic stem cells. Stem Cell Res 3, 3-11.